Clinical Trial Update: Study of Biomarker-Based Treatment of Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A biomarker-based treatment approach for acute myeloid leukemia is being studied in Phase 1/2 trials and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Beat AML, LLC | Conditions: Previously Untreated Relapsed Refractory Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING